![](https://cdn.sanity.io/images/0vv8moc6/hcplive/fda1cb71afd6bd44980e4dc595152f7a41e8428b-2009x2466.jpg?fit=crop&auto=format)
Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
Even with the second half of the trial yet to be completed, results of the CATALYST trial have initiated a potentially seismic shift in discussions around the management of type 2 diabetes. With the first part of the trial suggesting approximately 1-in-4 …